Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE flat as energy shares slump ahead of OPEC meeting

Thu, 27th Nov 2014 11:33

Heavy falls in the energy sector kept a lid on gains for the FTSE 100 on Thursday as investors awaited the outcome of a pivotal meeting of the Organization of Petroleum Exporting Countries (OPEC) in Vienna.London's benchmark index was up just 0.06% at 6,733 by midday. The index has traded broadly sideways since hitting a two-month high last week.While US markets will be closed for the Thanksgiving holiday, the OPEC meeting could prompt some volatility on open markets as crude prices extended a four-year low on the back of a supply glut.Brent crude fell the fourth day in London, dropping by 2.4% to $75.88 a barrel, a 50-month low, on speculation that OPEC members will not agree to a reduction in output."Each member of the oil cartel is effectively waiting for someone else to blink first, the consensus being 'we'll cut if they cut'. Whilst in theory this sounds sensible, with no one actually willing to cut, oil looks set for another precipitous fall," said analyst Connor Campbell from Spreadex."The FTSE is suffering at the hands of weak oil, due to the prevalence of energy companies making up the index," he said.Elsewhere, speeches from European Central Bank president Mario Draghi, and ECB members Jens Weidmann and Vitor Constancio were in focus on Thursday, along with data on German unemployment, inflation and consumer confidence.Energy shares slumpOil and gas producers such as BG Group, Tullow Oil, Shell, BP, Afren and Enquest were trading firmly in the red as shares tracked crude prices lower ahead of the outcome of the crucial OPEC meeting.BG Group was also feeling the heat as the proposed £25m pay package for its new boss Helge Lund continues to spark anger. The Institute of Directors branded the remuneration "excessive" and "inflammatory".Stocks in the energy services sector were also under pressure on concerns that lower prices could prompt producers to scale back on project spend. Petrofac, which delivered a profit warning to investors last week on the back of lower oil prices and the timing of contracts, was a heavy faller, along with Hunting and Amec Foster Wheeler.Amec Foster Wheeler, however, was also trading lower after going ex-dividend, meaning that investors will no longer have access to the company's latest payout. A number of stocks others also went ex-dividend on Thursday, including Dunelm, Johnson Matthey, Royal Mail, SABMiller, Vedanta Resources, Lancashire Holdings, Wolseley and JD Wetherspoon.Glaxosmithkline was subdued despite saying it is on track to complete its complex three-way £11bn deal with Swiss pharmaceutical peer Novartis next year after US regulators approved the first two parts of the transaction.Stagecoach saw shares surge after its 90%-owned joint venture with Virgin Rail won the contract from the Department for Transport to run the new InterCity East Coast franchise for eight years from March 2015.Supermarket chain J Sainsbury was under pressure after Shore Capital downgraded its rating from 'hold' to 'sell', saying investors should expect a "material contraction in profitability".Market MoverstechMARK 2,921.98 +0.36%FTSE 100 6,732.95 +0.06%FTSE 250 15,896.07 +0.68%FTSE 100 - RisersSmith & Nephew (SN.) 1,131.00p +2.17%Anglo American (AAL) 1,375.00p +2.04%ITV (ITV) 211.40p +2.03%Barclays (BARC) 242.10p +1.72%Intu Properties (INTU) 354.10p +1.64%Rio Tinto (RIO) 3,049.00p +1.57%Admiral Group (ADM) 1,233.00p +1.40%Coca-Cola HBC AG (CDI) (CCH) 1,447.00p +1.33%Mondi (MNDI) 1,083.00p +1.22%Land Securities Group (LAND) 1,187.00p +1.19%FTSE 100 - FallersPetrofac Ltd. (PFC) 874.00p -2.83%BG Group (BG.) 1,031.50p -1.72%Sainsbury (J) (SBRY) 235.10p -1.63%Morrison (Wm) Supermarkets (MRW) 178.70p -1.22%Royal Dutch Shell 'B' (RDSB) 2,339.00p -1.16%Tesco (TSCO) 185.10p -1.12%Royal Mail (RMG) 418.90p -0.99%Weir Group (WEIR) 2,038.00p -0.97%Sky (SKY) 915.50p -0.92%Rolls-Royce Holdings (RR.) 860.00p -0.81%FTSE 250 - RisersZoopla Property Group (WI) (ZPLA) 207.50p +9.10%Stagecoach Group (SGC) 397.70p +7.49%Shaftesbury (SHB) 809.50p +6.23%JD Sports Fashion (JD.) 507.00p +6.16%RPC Group (RPC) 577.00p +5.48%Riverstone Energy Limited (RSE) 905.00p +5.05%National Express Group (NEX) 252.20p +4.73%Thomas Cook Group (TCG) 118.80p +4.67%SSP Group (SSPG) 256.30p +4.61%Britvic (BVIC) 681.00p +3.97%FTSE 250 - FallersLancashire Holdings Limited (LRE) 546.50p -12.28%Amec Foster Wheeler (AMFW) 1,027.00p -3.02%EnQuest (ENQ) 63.10p -2.92%3i Infrastructure (3IN) 146.00p -2.28%Hunting (HTG) 659.50p -2.08%Afren (AFR) 63.95p -1.84%Spire Healthcare Group (SPI) 315.40p -1.59%Saga (SAGA) 154.20p -1.47%Tate & Lyle (TATE) 602.50p -1.47%Evraz (EVR) 150.30p -1.31%
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.